Towards an HIV Cure; understanding the major barriers | Sharon Lewin, AO, FRACP, PhD, FAHMS

APACC 2016

Transmitted drug resistance mutations among antiretroviral-naÏve adult patients in northern Vietnam | Vu Phuong Thao, PhD

APACC 2016

The impact of NRTI resistance on the public health approach to PI-based second-line therapy in resource limited settings | Thuy Le, MD, DPhil

APACC 2016

HIV Drug Resistance | Shinichi Oka, MD, PhD

APACC 2016

Next Generation Sequencing for Detection of Drug Resistance Mutations in HIV-1 | Dr. Rakhmanaliev

APACC 2016

They are not kids anymore: Standing at the crossroads of adolescent HIV Care | Annette Sohn, MD

APACC 2016

Elimination of perinatal HIV: the Role of Safer Conception Strategies | Shannon Weber, MSW

APACC 2016

Psychosocial Determinants of Anxiety and Depression among Children of HIV-infected Parents: a 3-year Longitudinal Study in Mainland China | Meiqi Xin

APACC 2016

The Patterns of Primary Cotrimoxazole Prophylaxis in Adult HIV Patients in HIV Integrated Clinic Cipto Mangunkusumo Hospital Jakarta in 2004-2013 | Ken Ayu Mastini

APACC 2016

TB Clinical Management Challenges | Nicholas Paton, MD, FRCP

APACC 2016

HIV surveillance – Are we missing out on key populations? | Yi-Chun Lo, MD

APACC 2016

Integrating PrEP in prevention | Robert Grant, MD, MPH

APACC 2016

Transmission networks among MSM | Shui-Shan Lee, MD, FRCP, FRCPA, FFPH

APACC 2016

Long-term comorbidities | Saye Khoo, MD, PhD

APACC 2016

Hyperlipidaemia and its association with CD4 recovery following antiretroviral therapy | Denise Chan

APACC 2016

Clinical case presentation | Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP

APACC 2016

Aspartate Aminotransferase to Platelet Ratio Index (APRI) is a Simple Test for Diagnosis Liver Cirrhosis in HIV Patients | Dr. K. Mariad

APACC 2016

Metabolic Syndrome among Malaysian HIV-Infected Patients: Preliminary Results from the HIV & Ageing Cohort | Sivaraj Naidu, MMedSc

APACC 2016

Sofosbuvir and Ribavirin therapy for the Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 and -2 Trials|||| Ledipasvir/Sofosbuvir for 12 Weeks in Patients Coinfected With HCV and HIV-1 | Dr. J. Rockstroh

APACC 2016

Development of HIV Vaccine Candidates for Prevention and Treatment | Sandhya Vasan, MD

APACC 2016

Clinical case presentation | Mark Nelson, MD

APACC 2016

APACC 2016

HIV Clinical Forum 2015

Resistance characteristics of Integrase Inhibitors - Charles Boucher, MD, PhD

HIV Clinical Forum 2015